Products
-
- BBB DamageCell Death and ApoptosisNeuroinflammationNeuronal Damage and RepairOxidative StressVascular Mechanisms
- 3D BBB Models
- Organ-on-a-Chip BBB ModelsTranswell Models3D BBB Models Culture Substrate
- 3D HydrogelsCollagensAnmial BBB ModelsCell Lines for BBB Modeling
- Immortalized CellsPrimary CellsStem Cells
Human Stomatin ELISA Kit (AC3787)
Cat.#: ASET-2376
Specifications
Description Human Stomatin ELISA Kit, a 90-minute assay kit, allows for the in vitro quantitative determination of human Stomatin concentrations in serum, plasma, and other biological fluids. Size 96T Sample Type Serum, plasma or other biological fluids. Reactivity Human Unit 1 kit Packaging Kit of pre-coated 96 well microplates (12 x 8 well strips) Detection Type Colorimetric Assay Type Quantitative Sensitivity 3.61 ng/L Precision Intra-assay CV: < 8%
Inter-assay CV: < 10%Product Range 50-800 ng/L Assay Time ~90 min Storage Store the unopened kit at +4°C. Shipping Wet ice Citation Guidance If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. Related Products
Cat.# Name Assay Type Price ASET-1340 Human PCTAIRE2 ELISA Kit (AC2751) Quantitative inquiry ASET-1462 Human Salusin alpha ELISA Kit (AC2873) Quantitative inquiry ASET-1006 Mouse SHC ELISA Kit (AC2417) Quantitative inquiry ASET-1671 Human KLC1 ELISA Kit (AC3082) Quantitative inquiry ASET-2056 Bovine Insulin ELISA Kit (AC3467) Quantitative inquiry ASET-1159 Mouse Cnrip1 ELISA Kit (AC2570) Quantitative inquiry ASET-1137 Rat SOX9 ELISA Kit (AC2548) Quantitative inquiry ASET-2440 Rat Semaphorin 3A ELISA Kit (AC3851) Quantitative inquiry ASET-2033 Rat Agrin ELISA Kit (AC3444) Quantitative inquiry ASET-2479 Rat ASRGL1 ELISA Kit (AC3890) Quantitative inquiry All of our products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
0Inquiry Basket